Page last updated: 2024-08-24

2,2'-dithiodiethanesulfonic acid and ifosfamide

2,2'-dithiodiethanesulfonic acid has been researched along with ifosfamide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brock, N; Pohl, J1
Brock, N; Stekar, J1
Ansorge, S; Brandis, M; Mohrmann, M; Schönfeld, B1
Kurowski, V; Wagner, T1

Trials

1 trial(s) available for 2,2'-dithiodiethanesulfonic acid and ifosfamide

ArticleYear
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
    Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged

1997

Other Studies

3 other study(ies) available for 2,2'-dithiodiethanesulfonic acid and ifosfamide

ArticleYear
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    IARC scientific publications, 1986, Issue:78

    Topics: Animals; Biotransformation; Cyclophosphamide; DNA; Glutathione; Ifosfamide; Kidney; Leukemia, Experimental; Mercaptoethanol; Mesna; Rats; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neoplasms

1986
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Arzneimittel-Forschung, 1982, Volume: 32, Issue:5

    Topics: Animals; Cyclophosphamide; Ifosfamide; Kidney Diseases; Mercaptoethanol; Mesna; Oxidation-Reduction; Rats; Rats, Inbred Strains

1982
Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells.
    Pediatric nephrology (Berlin, Germany), 1994, Volume: 8, Issue:4

    Topics: Animals; Cell Line; Cells, Cultured; Cyclophosphamide; DNA; DNA Replication; Drug Combinations; Ifosfamide; Kidney Tubules; Mesna; RNA; Thymidine; Uridine

1994